Paragon 28® was well represented at American College of Foot and Ankle Surgeons (ACFAS) Meeting on February 11th-14th. Management, sales representatives and engineers from Paragon 28 were on-hand to demonstrate and exhibit our multiple product lines to the thousands of foot and ankle surgeons in attendance. A Paragon 28 hosted event took place on Friday, February...
Paragon 28® is pleased to announce the launch of the V92 Cellular Bone Matrix. V92 is a viable allogeneic bone scaffold derived from bone marrow, in full compliance with FDA guidelines regarding human cells, tissues and cellular tissue-based products, and is intended for homologous use as a bone void filler. Key Features Two unique scaffold blends...
Paragon 28® received a design patent for the metatarsophalangeal (MTP) length restoration disc issued on October 15th, 2015. This allograft disc is a component of the PRESERVE™ Bone Graft System primarily for use in 1st MTP arthrodesis procedures. Harvested and cut from dense cancellous femoral bone, this graft provides exceptional vascularity while lengthening the 1st...
The name “Paragon 28” was chosen by design — to never lose focus on our goal to advance the science of foot and ankle surgery.
© 2025 Paragon 28, Inc.
